Drug Development Services Hong Kong

We leverage our experience to share unique perspectives and ultimately deliver your results. Partner with our Hong Kong team to access solutions from our neighboring operational units and global resources.

• Clinical Trial Support:Improve operational efficiencies and accelerate your timeline with our streamlined start-up process.
  • Early clinical/phase IIa
    • Clinical Pharmacology
    • Early Patient Studies
    • Clinical Trial Project Management and Monitoring
    • Complete PoC^®
  • Phase IIb/III
    • Xcellerate^®Clinical Trial Optimization^®
    • Clinical Trial Management
    • Xcellerate^®Monitoring
    • Drug Safety
    • Functional Service Provider
  • Life Cycle Management
  • Clinical Data Analysis and Reporting
  • Regulatory
• Central Laboratory Services: Trust in the experience of the Singapore central lab to deliver consistent, quality data and on-time data transfers for faster submissions. Operating since 2000, we offer one of the biggest central laboratories in the world, serving 16 countries in the Asia Pacific region. Central laboratory facilities and services are also available in Shanghai, China.
• Nonclinical Development Services: Leverage our dedicated expertise and operations across the region to deliver unique perspectives on your development program. Our CFDA GLP certified facility in Shanghai, China features a number of accreditations to fulfill global quality standards (FDA, OECD, etc.). Specific solutions for small molecules and biologics are available to reduce costs and gain efficiencies for your project.

As your partner, our diverse network of local scientific experts can meet your global requirements in any phase of drug development and help you reach decision points.

• Regulatory expertise: Get experienced consulting with your regulatory submissions from our local personnel.
• 网站监控: Ensure patient safety, data quality and your study’s integrity with our holistic site monitoring solutions.
• Project management: Receive expert guidance through any phase of your clinical trial by working alongside our dedicated project managers.
  
  

With a high density of international companies and Cantonese and English as the official languages, Hong Kong is considered a strategic location for business in the Asia Pacific region. Hong Kong has other attractive factors in the drug development landscape:

• Centralized infrastructure: Hong Kong’s concentrated patient population and centralized healthcare system make it natural choice for conducting clinical trials.
• Favorable regulatory environment: Typical approval timelines are three months and some accredited Hong Kong sites may also be used to support drug registration in China.
• Gateway to China: Based on location, language, and cultural similarities, Hong Kong is a natural base for connecting with Chinese collaborators.

Whether running a global trial in Hong Kong or including it as part of a regional Chinese-focused trial, we are ready to deliver your results.